StockData

Yarrow Bioscience, Inc. (YARW) stock

YARWNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 11/30102% above fair value
$14.21+0.28 (+2.01%)

Close on Nov 17, 2026Market cap $37.94MP/E –Yield –

Yarrow Bioscience cash

Cash and short-term investments held at the end of each period.

Yarrow Bioscience's cash was $22.93M at Jun 30, 2026. For fiscal 2025 it was $29.01M, down 52.8% from the year before. Over ten years it grew -4.0% a year on average. The highest annual figure on record is $136.25M in fiscal 2018.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$29.01M-52.8%
FY2024Dec 31, 2024$61.52M-34.1%
FY2023Dec 31, 2023$93.31M+201.0%
FY2022Dec 31, 2022$31.00M-27.7%
FY2021Dec 31, 2021$42.90M-27.8%
FY2020Dec 31, 2020$59.40M-3.0%
FY2019Dec 31, 2019$61.26M-55.0%
FY2018Dec 31, 2018$136.25M+108.0%
FY2017Dec 31, 2017$65.50M+111.9%
FY2016Dec 31, 2016$30.91M-29.4%
FY2015Dec 31, 2015$43.81M+15946.9%
FY2014Dec 31, 2014$273.00K–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$22.93M-54.4%
Q1 FY2026Mar 31, 2026$24.93M-59.5%
Q4 FY2025Dec 31, 2025$29.01M-58.7%
Q2 FY2025Jun 30, 2025$39.65M-49.2%
Q1 FY2025Mar 31, 2025$50.27M-41.5%
Q4 FY2024Dec 31, 2024$61.52M-34.1%
Q3 FY2024Sep 30, 2024$70.19M+354.3%
Q2 FY2024Jun 30, 2024$78.10M+278.5%
Q1 FY2024Mar 31, 2024$85.95M+184.5%
Q4 FY2023Dec 31, 2023$93.31M+201.0%
Q3 FY2023Sep 30, 2023$15.45M-56.5%
Q2 FY2023Jun 30, 2023$20.63M-51.8%
Q1 FY2023Mar 31, 2023$30.21M-40.9%
Q4 FY2022Dec 31, 2022$31.00M-27.7%
Q3 FY2022Sep 30, 2022$35.51M-32.9%
Q2 FY2022Jun 30, 2022$42.80M-58.8%
Q1 FY2022Mar 31, 2022$51.10M-57.6%
Q4 FY2021Dec 31, 2021$42.90M-27.8%
Q3 FY2021Sep 30, 2021$52.90M-31.2%
Q2 FY2021Jun 30, 2021$104.00M+3.6%
Q1 FY2021Mar 31, 2021$120.40M+45.6%
Q4 FY2020Dec 31, 2020$59.40M-3.0%
Q3 FY2020Sep 30, 2020$76.90M-21.2%
Q2 FY2020Jun 30, 2020$100.40M-8.2%
Q1 FY2020Mar 31, 2020$82.70M-31.9%
Q4 FY2019Dec 31, 2019$61.26M-55.0%
Q3 FY2019Sep 30, 2019$97.65M-36.0%
Q2 FY2019Jun 30, 2019$109.41M-28.8%
Q1 FY2019Mar 31, 2019$121.52M-22.0%
Q4 FY2018Dec 31, 2018$136.25M+108.0%
Q3 FY2018Sep 30, 2018$152.66M+920.6%
Q2 FY2018Jun 30, 2018$153.76M+1046.1%
Q1 FY2018Mar 31, 2018$155.84M+2484.8%
Q4 FY2017Dec 31, 2017$65.50M+111.9%
Q3 FY2017Sep 30, 2017$14.96M–
Q2 FY2017Jun 30, 2017$13.42M–
Q1 FY2017Mar 31, 2017$6.03M–
Q4 FY2016Dec 31, 2016$30.91M–

More Yarrow Bioscience figures

See a number that looks wrong?